Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2000
03/29/2000CN1050846C Antitumor antibiotic-Yunan-mycin and preparation process thereof
03/29/2000CN1050845C Compound Leustroducsin H, its use in medicine preparation and medicinal compositions having same
03/29/2000CN1050844C Protein kinase C inhibitors
03/29/2000CN1050843C Separation of cephalosporin isomers
03/29/2000CN1050841C Indole derivatives and medicinal composition having same
03/29/2000CN1050840C 咪唑脂氧合酶抑制剂 Imidazole lipoxygenase inhibitors
03/29/2000CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use
03/29/2000CN1050837C Continuous process for the manufacture of 2,5-dihydrofurans from gamma, delta-epoxybutenes
03/29/2000CN1050836C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates preparation process
03/29/2000CN1050835C 1,5-benzodiazepine derivatives and its preparation process and use in medicine
03/29/2000CN1050832C Process for preparing fibrinogen receptor antagonists
03/29/2000CN1050830C Hydroxy-substituted azetidinone compounds and its use in medicine
03/29/2000CN1050750C Useof magnesium-pyridoxal-5'-phosphate-glutaminate for prevention of diseases which result fromvascular lesions
03/29/2000CN1050749C Anti-inflammatory analogesic plaster
03/29/2000CA2281418A1 Use of a silicone gum to stabilize ascorbic acid and novel compositions containing these components
03/28/2000US6043389 Hydroxy and ether-containing oxyalkylene esters and uses thereof
03/28/2000US6043386 Non-calcemic, antiproliferative, transcriptionally active 24-fluorinated hybrid analogs of 1α,-25-dihydroxy vitamin D3
03/28/2000US6043373 Heterocycle-fused thiazole derivatives
03/28/2000US6043371 Reacting 3,5-dimethyl-2-methoxypyran-4-one compound with ammonia
03/28/2000US6043366 Useful in treating disorders involving the orphanin fq(a seventeen amino acid long peptide) receptor.
03/28/2000US6043365 Reacting biaryl or carbocyclic or heterocyclic isopropyl nitrile derivative with a lower alkyl ester of formic acid, condensing the intermediate formed with an aminoalkyl ester to obtain intermediate, cyclizing and condensing
03/28/2000US6043352 Increased hybridization binding affinity and nuclease resistance
03/28/2000US6043343 Amino acid sequence; for diagnosis and prevention of cancer and tumors; anticarcinogenic/antitumor agents; for screening compounds which bind to polypeptide
03/28/2000US6043285 Treating alzheimer's disease
03/28/2000US6043284 Anti-atherosclerotic diaryl compounds
03/28/2000US6043283 Administering tyramine compound to patient to inhibit injury, destruction or death of neurons
03/28/2000US6043281 Aldose reductase inhibitors; treatment or prevention of complications of diabetes
03/28/2000US6043280 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
03/28/2000US6043278 Perfluoralkyl substituted metallo-beta-lactamase inhibitors
03/28/2000US6043277 Retinoyloxy (alkyl-substituted) methyl butyrates useful for the treatment of gastrointestinal disorders, cutaneous ulcers and wounds
03/28/2000US6043276 Compounds obtained from salvia species having antiviral activity
03/28/2000US6043274 Method of treating diabetic cardiomyopathy
03/28/2000US6043273 Compositions, apparatus and methods for facilitating surgical procedures
03/28/2000US6043271 Method for the preparation of (±)-calanolide A and intermediates thereof
03/28/2000US6043268 Agent for treatment of viral infections
03/28/2000US6043266 Microbiocides treating gram-positive bacteria infections and persons with aids
03/28/2000US6043265 Isoxazolyl endothelin antagonists
03/28/2000US6043263 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
03/28/2000US6043261 Pyrrolodino imidines useful as nitric oxide synthase inhibitors
03/28/2000US6043260 Method of treating heart failure
03/28/2000US6043259 Treatment of cardiovascular and related pathologies
03/28/2000US6043258 Treatment of attention deficit hyperactivity disorder
03/28/2000US6043256 Antimutagenic agents
03/28/2000US6043255 Muscarinic antagonists
03/28/2000US6043254 Antiproliferative agent; enzyme inhibitor
03/28/2000US6043251 Treating muscular and nervous system disorders; including an effective amount of 2-amino-6-trifluoromethoxybenzothiazole
03/28/2000US6043250 Treating or preventing inflammatory diseases
03/28/2000US6043249 The compounds have either a sulfhydryl moiety or are reducible disulfides; antifolates
03/28/2000US6043248 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
03/28/2000US6043244 Method and composition for treating migraine
03/28/2000US6043243 Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug
03/28/2000US6043242 Imidazopyridazines
03/28/2000US6043240 Useful as antipsychotic and analgesic agents
03/28/2000US6043239 Heterocyclic compounds
03/28/2000US6043238 2-Aminobenzazapine derivatives
03/28/2000US6043237 Use of photodynamic therapy for prevention of secondary cataracts
03/28/2000US6043235 11β-aryl-17, 17-spirothiolane-substituted steroids
03/28/2000US6043234 Method for treating endometriosis or leiomyomata uteri with a competitive progesterone antagonist and a gestagen
03/28/2000US6043233 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
03/28/2000US6043231 Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
03/28/2000US6043229 Increased n-butyrate production will diminish the development of colon diseases notably of colon cancer.
03/28/2000US6043228 O6 -substituted guanine derivatives, a process for their preparation and their use in treating tumor cells
03/28/2000US6043226 3,6-ketal and enol ether macrolide antibiotics
03/28/2000US6043225 Diagnosis and treatment of arterial chlamydial granuloma
03/28/2000US6043224 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
03/28/2000US6043099 Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates
03/28/2000US6043098 Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates
03/28/2000US6043094 Therapeutic liposome composition and method
03/28/2000US6043091 Compound of 8 to 30 nucleobases targeted to coding region, 3' or 5'-untranslated region, or start codon of nucleic acid encoding a carbohydrate metabolism enzyme; for antidiabetic agents against non-insulin dependent diabetes
03/28/2000US6043081 Expression vectors encoding recombinant proteins comprising a VPR/VPX virion incorporation domain for targeting into HIV-1 or HIV-2 virions
03/28/2000US6043077 Directed aganist specific nucleotide sequences to inhibit replication, infectivity, or gene expression of the virus; for prevention or viricides with side effect reduction
03/28/2000US6043071 GlmU
03/28/2000US6043069 Catalytic antibodies and a method of producing same
03/28/2000US6043064 Efficient process using nocardia, amycolata, streptomyces, saccharopolyspora, amycolatopsis, saccharothrix, gilbertella or enzyme derived from these microorganisms to produce inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6043026 Mixture of an estrogen receptor modulator and a growth hormone secretagogue
03/28/2000US6042847 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
03/28/2000US6042846 Resistant to nuclease hydrolysis; efficiency
03/28/2000US6042845 Anti fungal treatment of nails
03/28/2000US6042840 Component of a skin care agent
03/28/2000US6042823 Ingesting an enzyme selected from amylase and invertase capable of acting in the living body together with a food material containing a substrate for forming oligosaccharide to prevent weight gain, diabetes, gastrointestinal disorders
03/28/2000US6042819 Hair treatment composition with long-lasting hair fixing properties
03/28/2000CA2245903A1 Use of pex in the treatment of metabolic bone diseases
03/28/2000CA2198084C Novel substituted piperidines useful for the treatment of allergic diseases
03/28/2000CA2180978C Pyrrolidine-containing monomers and oligomers
03/28/2000CA2180658C Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor
03/28/2000CA2177968C Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
03/28/2000CA2177821C Prolyl endopeptidase inhibitors
03/28/2000CA2164152C New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof
03/28/2000CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
03/28/2000CA2144974C Camphidine derivative, production thereof, and use thereof
03/28/2000CA2143000C Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
03/28/2000CA2139896C Use of antinauseant agent for terminally ill humans
03/28/2000CA2126086C Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
03/28/2000CA2109625C 3,5,3'-triiodothyronine receptor ligands
03/28/2000CA2063862C Topical preparation containing a suspension of solid lipid particles
03/28/2000CA2056662C Naphthoic acid derivative
03/28/2000CA2024964C N-azabicyclo{3.3.0|octane amides of aromatic acids
03/28/2000CA2014472C N-acyl derivatives of the ll-e33288 antitumor antibiotics
03/28/2000CA2014453C Adamantane-derivatives in the prevention and treatment of cerebral ischemia
1 ... 6343 6344 6345 6346 6347 6348 6349 6350 6351 6352 6353 6354 6355 6356 6357 6358 6359 6360 6361 6362 6363 ... 7860